Scientists have discovered a new strain of lactic acid bacterium that could significantly expand probiotic applications beyond the dairy industry. Researchers from the Agharkar Research Institute (ARI) in Pune, an autonomous institute under the Department of Science and Technology, have uncovered the hidden potential of Streptococcus thermophilus MCC0200 through collaborative genome analysis.
A detailed examination of the genetic makeup of strain MCC0200 revealed an array of genes linked to gastrointestinal survival, intestinal adhesion, and health-promoting functions, showcasing its probiotic capabilities.
One of the main challenges for any probiotic is surviving the harsh journey through the human digestive system. In vitro studies demonstrated that MCC0200 not only withstands the difficult conditions of the gastrointestinal tract but also shows remarkable resilience against gastric juices and bile acids, key factors in probiotic efficacy.
The study, published in the journal Microorganisms, delved deeper into the bacterium's genome and found genes that aid in acid tolerance and bile resistance, illuminating the molecular mechanisms behind its survival strategy.
MCC0200 thrives in the gut and has a strong affinity for intestinal surfaces, allowing it to interact with host cells. This ability to adhere to mucosal surfaces is crucial for promoting gut health and immune function. Additionally, MCC0200 can auto-aggregate and co-aggregate with pathogenic bacteria, essential traits for competitive exclusion and gut colonization.
The strain's antioxidative properties are also significant for gut health. MCC0200 can scavenge reactive oxygen species, protecting against oxidative stress-induced damage and maintaining gut redox balance.
Genome analysis also revealed MCC0200's ability to produce essential vitamins, including folate (vitamin B9). Folate is vital for various cellular functions, and MCC0200’s capacity to synthesize this nutrient could have substantial implications for human health, making it a valuable supplement for individuals deficient in these nutrients.
In the battle against cholesterol, MCC0200 has shown promising results. Studies indicate that this probiotic strain can assimilate cholesterol, potentially lowering serum cholesterol levels and reducing the risk of cardiovascular disease. Although the exact mechanism is still under investigation, MCC0200's cholesterol-lowering properties suggest it could be a functional food ingredient with cardiovascular benefits.
As research into probiotics' health benefits continues, Streptococcus thermophilus MCC0200 stands out for its diverse health-promoting attributes. Its unique combination of probiotic properties, along with its safety profile, makes it a promising candidate for food and pharmaceutical applications. With further exploration and innovation, MCC0200 could pave the way for a healthier future for all.